logo
CONTENT TYPES

Figure 1Loading Img

Rationally Designed Short Polyisoprenol-Linked PglB Substrates for Engineered Polypeptide and Protein N-Glycosylation

View Author Information
Department of Chemistry, Chemistry Research Laboratory, Oxford University, Oxford OX1 3TA United Kingdom
GlycoVaxyn AG, 8952 Schlieren, Switzerland
Cite this: J. Am. Chem. Soc. 2014, 136, 2, 566-569
Publication Date (Web):December 16, 2013
https://doi.org/10.1021/ja409409h
Copyright © 2013 American Chemical Society
Authors ChoiceACS AuthorChoice
with CC-BY license
Article Views
3453
Altmetric
-
Citations
LEARN ABOUT THESE METRICS

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

PDF (1 MB)
Supporting Info (1)»

Abstract

The lipid carrier specificity of the protein N-glycosylation enzyme C. jejuni PglB was tested using a logical, synthetic array of natural and unnatural C10, C20, C30, and C40 polyisoprenol sugar pyrophosphates, including those bearing repeating cis-prenyl units. Unusual, short, synthetically accessible C20 prenols (nerylnerol 1d and geranylnerol 1e) were shown to be effective lipid carriers for PglB sugar substrates. Kinetic analyses for PglB revealed clear KM-only modulation with lipid chain length, thereby implicating successful in vitro application at appropriate concentrations. This was confirmed by optimized, efficient in vitro synthesis allowing >90% of Asn-linked β-N-GlcNAc-ylated peptide and proteins. This reveals a simple, flexible biocatalytic method for glycoconjugate synthesis using PglB N-glycosylation machinery and varied chemically synthesized glycosylation donor precursors.

Protein glycosylation is a vital co- or post-translational modification that links glycans to proteins typically through N- or O- linkages. Such modifications exist widely in eukaryotic and archaeal organisms and greatly expand the diversity of the proteome.(1-3) While N-linked glycosylation had been believed to be absent in prokaryotic systems, the discovery of the protein N-glycosyltransferase PglB in Gram-negative bacterium Campylobacter jejuni highlighted greater diversity; PglB is responsible for glycosylating over 50 different proteins.(4-7) Since then PglB orthologues have been found in Campylobacter lari,(8) the Helicobacter genus (H. pullorum, H. canadensis, H. winghamensis)(9) as well as Desulfovibrio desulfuricans(10) and, very recently, Methanococcus voltae.(11)In vivo PglB uses a C55 undecaprenylpyrophosphate-linked oligosaccharide as its substrate and glycosylates the primary amide nitrogen of the asparagine side chain in a D/E-X-N-X-T/S consensus sequence (where X can be any amino acid except proline, Figure 1). In contrast to its eukaryotic counterpart Stt3p, PglB does not require other proteins/subunits and can apparently catalyze this N-glycosylation in vivo alone.(12) Moreover, in vivo biosynthetic studies that allowed exposure of PglB to other lipid-linked oligosaccharides have suggested a possibly relaxed specificity toward the nature of glycan substrate, as compared to the relatively highly specific eukaryotic N-glycosylation enzymes.(13) Recent elegant approaches flexibly using PglB in vivo have been developed to prepare glycoproteins.(14, 15) These distinct characteristics of PglB, as well as the fact that C. jejuni PglB can be readily overexpressed in functional form in Escherichia coli,(16) highlight PglB’s potential as a synthetic biocatalyst. They suggest it as a potentially ideal model from which to generate a ready synthetic system for in vitro protein glycosylation. However, the donor substrates used normally by PglB in vivo (C55 lipid pyrophosphoryl-linked oligosaccharides containing the rare, bacterial sugar bacillosamine (Bac)) would restrict this system (both in substrate accessibility and product relevance).

Figure 1

Figure 1. Bacterial N-linked glycosylation and designed unnatural candidate polyprenols 1ag as alternative short lipid carriers for PglB-catalyzed glycosylation. The polyprenols were synthesized from building blocks 2ad and 3a and 3b.

In an attempt to optimize the PglB protein N-glycosylation platform for practical, synthetic (and hence in vitro) use, we designed an array of chemically generated polyisoprenol variants to find those simpler and shorter than the natural undecaprenol (Figure 1) and that might serve as alternative lipid carriers that could be recognized by PglB. Insightful prior work has elucidated some aspects of the polyisoprenol specificity of PglB.(17, 18) However, estimated conversions for these reactions were ≤20%. In addition, many of these prior substrates were prepared enzymatically from polyisoprenols isolated from natural sources, enabling only nmol analysis of lipid pyrophosphates containing the natural Campylobacter (GalNAc-GalNAc-BacdiNAc) glycans. This revealed tantalizing activity for two shorter (mixed cis/trans prenol-9 and prenol-8) variants. However, despite some individual pioneering examples(19-28) synthetic access to other prenols has been rare, and homologated families of lipids have not yet been probed. Therefore, with the intention of probing fuller lipid and sugar substrate plasticity and breadth in PglB and with the intention of creating synthetically accessible substrates, we first systematically varied the lipid carriers (Figure 1).

Scheme 1

Scheme 1. Syntheses of Polyprenol Variantsa

a(i) BuLi, THF, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMTP), −78 °C. Yield: 4a = 92%, 4b = 93%, 4c = 83%, 4d = 63%, 4e = 67%, 4f = 74%. (ii) (1) TBAF, THF, RT, 4 h; (2) LiEt3BH, (dppp)PdCl2, THF, 0 °C–RT. Yield: 1a= 65%, 1b = 57%, 1c = 50%, 1d = 70%, 1e = 60%, 1f = 54%.

As a starting point for lipid variation, we speculated that the use of repeating cis-prenyl units at the hydroxyl terminus would confer binding affinity due to a resemblance to the alcohol-terminus that bears the glycan-pyrophosphate found in the natural substrate and likely enters a binding pocket in PglB.(29) This notion is supported by a crystal structure which has a Mg2+ bound at the active site.(29) Subsequent modeling suggested that the lipid carrier would likely locate first in a narrow pocket that would tightly accommodate two isoprenyl units (and thus impose tighter stereochemical requirements) and then along a broader hydrophobic groove with potentially more relaxed requirements (Figure S12). Thus, compounds 1ag, all bearing one or more terminal repeating cis-prenyl units were designed and synthesized as primary candidate lipid carriers (Figure 1). In brief (see SI for further details), compounds 1af were synthesized from head (compound 3a and 3b) and tail building blocks (compound 2ad). The requisite building blocks were prepared and elongated using coupling between appropriate sulfones and allyl chloride. Utilization of a convergent synthetic strategy in the case of long lipids (Scheme 1) allowed useful flexibility in the generation of lipids with different stereochemistry. Removal of sulfonyl groups in one step using LiEt3BH/(dppp)PdCl2 valuably reduced both the total number of synthetic steps and the formation of isomeric products resulting from double-bond migration and basic conditions.(23, 25) The resulting, pure synthetic polyprenols were shown to have a d.r. (E/Z) > 95% according to the characteristic allylic methyl group signals in 1H NMR (see Figure S1); no unwanted isomeric product (<2%, 1H NMR signals at δ 2.7, 5.9 ppm)(30) was detected.

These polyprenols were readily phosphorylated using mono(tetrabutylammonium) phosphate (TBAP) activated with trichloroacetonitrile (TCA).(31) We next attached just a single residue atypical glycan to provide a stringent test of the catalytic activity of PglB. Importantly, we used the sugar that would be found as the first N-linked residue in eukaryotic glycoproteins (but not prokaryotic and so not that normally employed by Campylobacter): GlcNAc. The resulting polyprenyl monophosphates 5ag were therefore coupled to 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-d-glucopyranose 1-phosphate (6) using carbonyldiimidazole (CDI)-mediated phosphoesterification.(32, 33) Deacetylation with catalytic NaOMe in MeOH (Zemplén conditions) gave the lipid pyrophosphate-linked saccharides (LPPS) 8ag in 9–38% yield over three steps (Scheme 2).

Scheme 2

Scheme 2. Syntheses of Lipid-linked Oligosaccharides and use in Glycopeptide Synthesisa

a(i) 5ag, TBAP, TCA, DCM, RT; 5h, POCl3, Et3N, 2h. (ii) (1) CDI, DMF; (2) MeOH; (3) 6, DMF, RT, 3–5 days. (iii) NaOMe, MeOH. Yield over 3 steps: 8a = 17%, 8b = 23%, 8c = 9%, 8d = 17%, 8e = 9%, 8f = 38%, 8g = 29%, 8h = 32%, 13 = 22%, 14 = 30%. Extension reactions (blue arrows, 5–94%); see SI for further details.

With these first synthetic LPPS’s in hand, 8ah were then tested as substrates of PglB. The glycosylation of peptides bearing the required D/E-X-N-X-S/T consensus motif was determined by examining the increase of molecular weight (16%/6 M urea tricine-SDS-PAGE)(34) that corresponds to the addition of GlcNAc (Figure 2). An extract from E. coli LPPS containing C. jejuni heptasaccharide-linked undecaprenyl pyrophosphate was used as a positive control. Excitingly, 8ae were active substrates for PglB-catalyzed N-glycosylation of the fluorescent peptide Tamra-DANYTK as indicated by the appearance of glycopeptide product bands with higher molecular weight consistent with the addition of GlcNAc. This importantly revealed that the lipid carrier for the substrate of PglB can contain as few as two cis-head repeating units. The activity of 8c and 8e as substrates for PglB also indicated that PglB can tolerate lipid carriers bearing trans geometry close to the hydroxyl terminus. However, activity was lost as the length of lipid became shorter than four prenyl units: nerol (1g)-PP-GlcNAc (8g), cis,cis-farnesol (1f)-PP-GlcNAc conjugate (8f), and citronellol-PP-GlcNAc conjugate (8h)(32, 33) did not show any detectable activity in the in vitro assay. These activities ‘mapped’ tight proximal-site activity and relaxed distal-site activity consistent with model shown in Figure S12.

Figure 2

Figure 2. Peptide and protein glycosylation. (a) Fluorescent electrophoretic analysis of peptide glycosylation with lipids (8ah) (− = no lipid; + = lipid extracted and enriched from E. coli cells producing C. jejuni heptasaccharide-linked undecaprenyl pyrophosphate); [glycolipid] = [peptide] 20 μM; [PglB] = 0.44 μM. (b) ES-MS of in vitro N-linked protein (AcrA) glycosylation with 8c; >95% diglycosylation.

These first kinetic parameters (Table 1) for PglB suggested key features. In particular, the variation of activity with lipid length in the substrate is strikingly only dependent on KM; kcat remains essentially unaltered. This suggests that the lipid may not play a primary role in catalytic turnover but is a key regulator of substrate uptake. This suggested too that in vitro reactions conducted at sufficiently high concentrations >KM would allow transfer efficiencies equal to those found for full length lipid substrates. This was valuably confirmed in synthetic reactions that allowed the synthesis of GlcNAc-ylated glycopeptide in yields >90% using 0.1 mM glycosyl donor substrate 8c with 20 μM of acceptor peptide. These >90% reactions usefully extend(17, 18) the synthetic utility of PglB.

Table 1. Kinetic Parameters for PglB with GlcNAc Lipidsa
glycolipid substratekcat [min–1]KM [mM]kcat/KM [min–1mM–1]
8d GlcNAc-PP-ωZ30.0234 ± 0.00210.077 ± 0.0160.30
8c GlcNAc-PP-ωEZ40.0231 ± 0.00160.055 ± 0.010.42
8a GlcNAc-PP-prenol80.0225 ± 0.00210.034 ± 0.010.66
a

UPLC using TAMRA-fluorescence intensity; substrate concentrations: [glycolipid] = 1, 5, 10, 50, 100, 200 μM, [peptide] = 20 μM; enzyme concentration [PglB] = 0.44 μM; reaction time <2h, 30 °C; all conducted in duplicate.

Having elucidated valuable plasticity toward unnatural lipid-variant substrates, we next examined glycan breadth beyond the atypical monosaccharide GlcNAc already demonstrated. Conjugates (13 and 14) that contain both unnatural sugar and lipid carrier (Scheme 2) were prepared by coupling nerylnerylphosphate (5d) with the 6-azido-GlcNAc (9) and 2-azidoGlcNAc (10, GlcNAz). These compounds would allow subsequent flexible postexpressional modifications on proteins that contain D/E-X-N-X-S/T tag via reaction of the introduced azide with a number of compatible methods. Both azido analogues (13 and 14) failed to undergo glycosylation with the peptide in the presence of PglB. The failure of these glycolipids to act as substrates may be explained by the use of nonpreferred moieties in both halves of these unnatural sugar-unnatural lipid conjugates. It may also suggest a particular lack of plasticity by PglB toward alterations at sugar sites C-2 or C-6; glycolipids 13 and 14 did not inhibit PglB glycosylations using 8c (see SI).

GlcNAc-ylated peptide could then be extended (Scheme 2) with the use of endoglycosidases(35, 36) (EndoS,(37) EndoA,(15, 38, 39) Scheme 2) and glycosyltransferases (β-1,4-GalT).(40) This allowed ready access to differently elaborated glycopeptides bearing, e.g., LacNAc (94%), or the eukaryotic N-glycan core-pentasaccharide (64%). Finally, we then tested the ability of this system to glycosylate proteins. Using short GlcNAc-lipids 8c and 8e, we could effect in vitro glycosylation >95% at the two consensus Asn sites in the C. jejuni AcrA(14) protein.

In conclusion, a wide variety of cis-polyisoprenol variants were chemically synthesized and studied for their binding specificity against PglB. For the first time, LPPS’s with only a single sugar and lipid chain lengths as short as C20 and C30 have been shown to be effective substrates for PglB in glycosylating specific peptide motifs. This reveals unexpected breadth for PglB beyond the minimal C40 lipid-trisaccharide substrate determined previously.(17) Our experimental catalytic data are consistent with previous crystallographic and modeling analyses. A closer examination of the lipid-binding pocket also reveals a relationship between the PglB structure and the chain length requirements that we have discovered here. The narrow pocket that precedes the hydrophobic groove is surrounded by polar residues Ser198, Ser201, Arg375. Longer lipid chains beyond the third isoprenyl unit may be required for increased affinity, by favorable interaction with the hydrophobic groove. This explains the observation that 8e was an active substrate, but 8f was not. Similar studies on the lipid carrier specificity of MurG have however shown a quite different trend, in which nerol (1g) and nerylnerol (1d) conjugates were much better substrates than those of longer lipids bearing repeating cis units.(24, 41, 42) Investigation of the crystal structures of MurG and/or PglB with lipid carrier bound, once available, would shed light on these clear differences in lipid carrier specificities.

The discovery of the breadth of PglB and these accessible lipid carriers now effectively enables the synthesis of lipid-pyrophosphate-linked substrates suitable for the in vitro generation of tailor-made glycoproteins. Importantly, to our knowledge, this currently represents the only in vitro biocatalytic system for the formation of the vital GlcNAc-β-1-N-Asn linkage (and importantly can be driven to >95% on proteins, here for AcrA); the recently discovered Methanococcus AglB, e.g.,(11) does not transfer GlcNAc and requires an unusual disaccharide. This discovery complements prior GalNAc transfer and confirms a predicted activity.(18) Notably, WecA,(43) the enzyme that would generate PP-linked glycolipid substrates for PglB, is membrane-associated and cannot be readily exploited in vitro. In vitro biocatalytic installation of GlcNAc, shown here, also creates a useful precursor sugar site for carbohydrate-processing enzyme-mediated extension, as shown here (Scheme 2). The >90% in vitro efficiencies shown here therefore make PglB a highly viable synthetic biocatalyst for varied glycopolypeptides, coupled with substrate accessibility and potential for further enzymatic transformation.

Supporting Information

ARTICLE SECTIONS
Jump To

Full procedures. This material is available free of charge via the Internet at http://pubs.acs.org.

§Author Contributions

These authors contributed equally.

The authors declare the following competing financial interest(s): M.K. and A.F. are employees of Glycovaxyn. A patent has been filed and will afford inventors royalties, if licensed, in line with university guidelines.

Terms & Conditions

Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

Acknowledgment

ARTICLE SECTIONS
Jump To

We thank the BBSRC (T.A.T.), Glycovaxyn (F.L., B.V., B.G.D.) for funding, Drs P. Carranza, C. Bich for method development and glycopeptide analysis, and Drs L. Gong, J. Wickens for HRMS analysis. B.G.D. is a Royal Society Wolfson Merit Research Award Recipient.

References

ARTICLE SECTIONS
Jump To

This article references 43 other publications.

  1. 1
    Spiro, R. G. Glycobiology 2002, 12, 43R
  2. 2
    Walsh, C. T.; Garneau-Tsodikova, S.; Gatto, G. J. Angew. Chem., Int. Ed. 2005, 44, 7342
  3. 3
    Ohtsubo, K.; Marth, J. D. Cell 2006, 126, 855
  4. 4
    Szymanski, C. M.; Yao, R.; Ewing, C. P.; Trust, T. J.; Guerry, P. Mol. Microbiol. 1999, 32, 1022
  5. 5
    Young, N. M.; Brisson, J. R.; Kelly, J.; Watson, D. C.; Tessier, L.; Lanthier, P. H.; Jarrell, H. C.; Cadotte, N.; St Michael, F.; Aberg, E.; Szymanski, C. M. J. Biol. Chem. 2002, 277, 42530
  6. 6
    Linton, D.; Allan, E.; Karlyshev, A. V.; Cronshaw, A. D.; Wren, B. W. Mol. Microbiol. 2002, 43, 497
  7. 7
    Scott, N. E.; Parker, B. L.; Connolly, A. M.; Paulech, J.; Edwards, A. V. G.; Crossett, B.; Falconer, L.; Kolarich, D.; Djordjevic, S. P.; Højrup, P.; Packer, N. H.; Larsen, M. R.; Cordwell, S. J. Mol. Cell. Proteomics 2011, 10, M000031
  8. 8
    Schwarz, F.; Lizak, C.; Fan, Y.-Y.; Fleurkens, S.; Kowarik, M.; Aebi, M. Glycobiology 2011, 21, 45
  9. 9
    Jervis, A. J.; Langdon, R.; Hitchen, P.; Lawson, A. J.; Wood, A.; Fothergill, J. L.; Morris, H. R.; Dell, A.; Wren, B.; Linton, D. J. Bacteriol. 2010, 192, 5228
  10. 10
    Ielmini, M. V.; Feldman, M. F. Glycobiology 2011, 21, 734
  11. 11
    Larkin, A.; Chang, M. M.; Whitworth, G. E.; Imperiali, B. Nat. Chem. Biol. 2013, 9, 367
  12. 12
    Glover, K. J.; Weerapana, E.; Numao, S.; Imperiali, B. Chem. Biol. 2005, 12, 1311
  13. 13
    Wacker, M.; Feldman, M. F.; Callewaert, N.; Kowarik, M.; Clarke, B. R.; Pohl, N. L.; Hernandez, M.; Vines, E. D.; Valvano, M. A.; Whitfield, C.; Aebi, M. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 7088
  14. 14
    Feldman, M. F.; Wacker, M.; Hernandez, M.; Hitchen, P. G.; Marolda, C. L.; Kowarik, M.; Morris, H. R.; Dell, A.; Valvano, M. A.; Aebi, M. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 3016
  15. 15
    Schwarz, F.; Huang, W.; Li, C.; Schulz, B. L.; Lizak, C.; Palumbo, A.; Numao, S.; Neri, D.; Aebi, M.; Wang, L.-X. Nat. Chem. Biol. 2010, 6, 264
  16. 16
    Wacker, M.; Linton, D.; Hitchen, P. G.; Nita-Lazar, M.; Haslam, S. M.; North, S. J.; Panico, M.; Morris, H. R.; Dell, A.; Wren, B. W.; Aebi, M. Science 2002, 298, 1790
  17. 17
    Chen, M. M.; Weerapana, E.; Ciepichal, E.; Stupak, J.; Reid, C. W.; Swiezewska, E.; Imperiali, B. Biochemistry 2007, 46, 14342
  18. 18
    Li, L.; Woodward, R.; Ding, Y.; Liu, X.-w.; Yi, W.; Bhatt, V. S.; Chen, M.; Zhang, L.-w.; Wang, P. G. Biochem. Biophys. Res. Commun. 2010, 394, 1069
  19. 19
    Sato, K.; Inoue, S.; Onishi, A.; Uchida, N.; Minowa, N. J. Chem. Soc., Perkin Trans. 1 1981, 761
  20. 20
    Sato, K.; Miyamoto, O.; Inoue, S.; Furusawa, F.; Matsuhashi, Y. Chem. Lett. 1983, 12, 725
  21. 21
    Jaenicke, L.; Siegmund, H. Biol. Chem. Hoppe-Seyler 1986, 367, 787
  22. 22
    Inoue, S.; Kaneko, T.; Takahashi, Y.; Miyamoto, O.; Sato, K. J. Chem. Soc., Chem. Commun. 1987, 1036
  23. 23
    Grassi, D.; Lippuner, V.; Aebi, M.; Brunner, J.; Vasella, A. J. Am. Chem. Soc. 1997, 119, 10992
  24. 24
    Chen, L.; Men, H.; Ha, S.; Ye, X.-Y.; Brunner, L.; Hu, Y.; Walker, S. Biochemistry 2002, 41, 6824
  25. 25
    Chang, Y.-F.; Liu, C.-Y.; Guo, C.-W.; Wang, Y.-C.; Fang, J.-M.; Cheng, W.-C. J. Org. Chem. 2008, 73, 7197
  26. 26
    Meng, F.-C.; Chen, K.-T.; Huang, L.-Y.; Shih, H.-W.; Chang, H.-H.; Nien, F.-Y.; Liang, P.-H.; Cheng, T.-J. R.; Wong, C.-H.; Cheng, W.-C. Org. Lett. 2011, 13, 5306
  27. 27
    Hesek, D.; Lee, M.; Zajíček, J.; Fisher, J. F.; Mobashery, S. J. Am. Chem. Soc. 2012, 134, 13881
  28. 28
    Shih, H.-W.; Chang, Y.-F.; Li, W.-J.; Meng, F.-C.; Huang, C.-Y.; Ma, C.; Cheng, T.-J. R.; Wong, C.-H.; Cheng, W.-C. Angew. Chem., Int. Ed. 2012, 51, 10123
  29. 29
    Lizak, C.; Gerber, S.; Numao, S.; Aebi, M.; Locher, K. P. Nature 2011, 474, 350
  30. 30
    Jaenicke, L.; Siegmund, H.-U. Chem. Phys. Lipids 1989, 51, 159
  31. 31
    Danilov, L. L.; Druzhinina, T. N.; Kalinchuk, N. A.; Maltsev, S. D.; Shibaev, V. N. Chem. Phys. Lipids 1989, 51, 191
  32. 32
    Bernardes, G. J. L.; Davis, B. G. unpublished results, University of Oxford, 2007.
  33. 33
    Bernardes, G. J. L.; Kikkeri, R.; Maglinao, M.; Laurino, P.; Collot, M.; Hong, S. Y.; Lepenies, B.; Seeberger, P. H. Org. Biomol. Chem. 2010, 8, 4987
  34. 34
    Schagger, H. Nat. Protoc. 2006, 1, 16
  35. 35
    Wang, L.-X. Carbohydr. Res. 2008, 343, 1509
  36. 36
    Rich, J. R.; Withers, S. G. Nat. Chem. Biol. 2009, 5, 206
  37. 37
    Goodfellow, J. J.; Baruah, K.; Yamamoto, K.; Bonomelli, C.; Krishna, B.; Harvey, D. J.; Crispin, M.; Scanlan, C. N.; Davis, B. G. J. Am. Chem. Soc. 2012, 134, 8030
  38. 38
    Fernández-González, M.; Boutureira, O.; Bernardes, G. J.; Chalker, J. M.; Young, M.; Errey, J.; Davis, B. G. Chem. Sci. 2010, 1, 709
  39. 39
    Lomino, J. V.; Naegeli, A.; Orwenyo, J.; Amin, M. N.; Aebi, M.; Wang, L.-X. Bioorg. Med. Chem. 2013, 21, 2262
  40. 40
    Gamblin, D. P.; Garnier, P.; van Kasteren, S.; Oldham, N. J.; Fairbanks, A. J.; Davis, B. G. Angew. Chem., Int. Ed. 2004, 43, 828
  41. 41
    Ye, X.-Y.; Lo, M.-C.; Brunner, L.; Walker, D.; Kahne, D.; Walker, S. J. Am. Chem. Soc. 2001, 123, 3155
  42. 42
    Liu, C.-Y.; Guo, C.-W.; Chang, Y.-F.; Wang, J.-T.; Shih, H.-W.; Hsu, Y.-F.; Chen, C.-W.; Chen, S.-K.; Wang, Y.-C.; Cheng, T.-J.; Ma, C.; Wong, C.-H.; Fang, J.-M.; Cheng, W.-C. Org. Lett. 2010, 12, 1608
  43. 43
    Lehrer, J.; Vigeant, K. A.; Tatar, L. D.; Valvano, M. A. J. Bacteriol. 2007, 189, 2618

Cited By


This article is cited by 19 publications.

  1. Patrick G. Isenegger, Benjamin G. Davis. Concepts of Catalysis in Site-Selective Protein Modifications. Journal of the American Chemical Society 2019, 141 (20) , 8005-8013. DOI: 10.1021/jacs.8b13187.
  2. Ryan P. Sweeney, Todd L. Lowary. A Route to Polyprenol Pyrophosphate-Based Probes of O-Polysaccharide Biosynthesis in Klebsiella pneumoniae O2a. Organic Letters 2019, 21 (4) , 1050-1053. DOI: 10.1021/acs.orglett.8b04093.
  3. Kohki Fujikawa, Sonomi Suzuki, Ryohei Nagase, Shiori Ikeda, Shoko Mori, Kaoru Nomura, Ken-ichi Nishiyama, Keiko Shimamoto. Syntheses and Activities of the Functional Structures of a Glycolipid Essential for Membrane Protein Integration. ACS Chemical Biology 2018, 13 (9) , 2719-2727. DOI: 10.1021/acschembio.8b00654.
  4. Chao Li, Lai-Xi Wang. Chemoenzymatic Methods for the Synthesis of Glycoproteins. Chemical Reviews 2018, 118 (17) , 8359-8413. DOI: 10.1021/acs.chemrev.8b00238.
  5. Vinita Lukose, Garrett Whitworth, Ziqiang Guan, and Barbara Imperiali . Chemoenzymatic Assembly of Bacterial Glycoconjugates for Site-Specific Orthogonal Labeling. Journal of the American Chemical Society 2015, 137 (39) , 12446-12449. DOI: 10.1021/jacs.5b07146.
  6. Charlotte Olagnon, Julia Monjaras Feria, Clemens Grünwald‐Gruber, Markus Blaukopf, Miguel A. Valvano, Paul Kosma. Synthetic Phosphodiester‐Linked 4‐Amino‐4‐deoxy‐ l ‐arabinose Derivatives Demonstrate that ArnT is an Inverting Aminoarabinosyl Transferase. ChemBioChem 2019, 20 (23) , 2936-2948. DOI: 10.1002/cbic.201900349.
  7. Antony J Fairbanks. Chemoenzymatic synthesis of glycoproteins. Current Opinion in Chemical Biology 2019, 53, 9-15. DOI: 10.1016/j.cbpa.2019.05.015.
  8. Ana S. Ramírez, Jérémy Boilevin, Ahmad Reza Mehdipour, Gerhard Hummer, Tamis Darbre, Jean-Louis Reymond, Kaspar P. Locher. Structural basis of the molecular ruler mechanism of a bacterial glycosyltransferase. Nature Communications 2018, 9 (1) DOI: 10.1038/s41467-018-02880-2.
  9. Maja Napiórkowska, Jérémy Boilevin, Tamis Darbre, Jean-Louis Reymond, Kaspar P. Locher. Structure of bacterial oligosaccharyltransferase PglB bound to a reactive LLO and an inhibitory peptide. Scientific Reports 2018, 8 (1) DOI: 10.1038/s41598-018-34534-0.
  10. , , Aravind Natarajan, Thapakorn Jaroentomeechai, Mingji Li, Cameron J. Glasscock, Matthew P. DeLisa. Metabolic engineering of glycoprotein biosynthesis in bacteria. Emerging Topics in Life Sciences 2018, 2 (3) , 419-432. DOI: 10.1042/ETLS20180004.
  11. Yin Yao Dong, Hua Wang, Ashley C. W. Pike, Stephen A. Cochrane, Sadra Hamedzadeh, Filip J. Wyszyyski, Simon R. Bushell, Sylvain F. Royer, David A. Widdick, Andaleeb Sajid, Helena I. Boshoff, Ricardo Lucas, Wei-Min Liu, Seung Seo Lee, Takuya Machida, Shahid Mehmood, Katsiaryna Belaya, Wei-Wei Liu, Amy Chu, Leela Shrestha, Shubhashish M. M. Mukhopadhyay, Nicola A. Burgess-Brown, Mervyn J. Bibb, Clifton E. Barry III, Carol V. Robinson, David Beeson, Benjamin G. Davis, Elisabeth P. Carpenter. Structures of DPAGT1 Explain Glycosylation Disease Mechanisms and Advance TB Antibiotic Design. SSRN Electronic Journal 2018, DOI: 10.2139/ssrn.3188395.
  12. Maja Napiórkowska, Jérémy Boilevin, Tina Sovdat, Tamis Darbre, Jean-Louis Reymond, Markus Aebi, Kaspar P Locher. Molecular basis of lipid-linked oligosaccharide recognition and processing by bacterial oligosaccharyltransferase. Nature Structural & Molecular Biology 2017, 24 (12) , 1100-1106. DOI: 10.1038/nsmb.3491.
  13. Shiteshu Shrimal, Natalia A Cherepanova, Reid Gilmore. One flexible loop in OST lassos both substrates. Nature Structural & Molecular Biology 2017, 24 (12) , 1009-1010. DOI: 10.1038/nsmb.3508.
  14. Ana S Ramírez, Jérémy Boilevin, Rasomoy Biswas, Bee Ha Gan, Daniel Janser, Markus Aebi, Tamis Darbre, Jean-Louis Reymond, Kaspar P Locher. Characterization of the single-subunit oligosaccharyltransferase STT3A from Trypanosoma brucei using synthetic peptides and lipid-linked oligosaccharide analogs. Glycobiology 2017, 27 (6) , 525-535. DOI: 10.1093/glycob/cwx017.
  15. Michaël Bosco, Ahmad Massarweh, Soria Iatmanen-Harbi, Ahmed Bouhss, Isabelle Chantret, Patricia Busca, Stuart E.H. Moore, Christine Gravier-Pelletier. Synthesis and biological evaluation of chemical tools for the study of Dolichol Linked Oligosaccharide Diphosphatase (DLODP). European Journal of Medicinal Chemistry 2017, 125, 952-964. DOI: 10.1016/j.ejmech.2016.10.013.
  16. Mijoon Lee, Dusan Hesek, Jaroslav Zajíček, Jed F. Fisher, Shahriar Mobashery. Synthesis and shift-reagent-assisted full NMR assignment of bacterial ( Z8 , E2 ,ω)-undecaprenol. Chemical Communications 2017, 53 (95) , 12774-12777. DOI: 10.1039/C7CC06781J.
  17. Takuya Machida, Nicolas Winssinger. One-Step Derivatization of Reducing Oligosaccharides for Rapid and Live-Cell-Compatible Chelation-Assisted CuAAC Conjugation. ChemBioChem 2016, 17 (9) , 811-815. DOI: 10.1002/cbic.201600003.
  18. Camilo Perez, Sabina Gerber, Jérémy Boilevin, Monika Bucher, Tamis Darbre, Markus Aebi, Jean-Louis Reymond, Kaspar P. Locher. Structure and mechanism of an active lipid-linked oligosaccharide flippase. Nature 2015, 524 (7566) , 433-438. DOI: 10.1038/nature14953.
  19. Akihiro Ishiwata, Yuya Taguchi, Yong Joo Lee, Taisuke Watanabe, Daisuke Kohda, Yukishige Ito. N-Glycosylation with Synthetic Undecaprenyl Pyrophosphate-Linked Oligosaccharide to Oligopeptides by PglB Oligosaccharyltransferase from Campylobacter jejuni. ChemBioChem 2015, 16 (5) , 731-737. DOI: 10.1002/cbic.201402658.
  • Abstract

    Figure 1

    Figure 1. Bacterial N-linked glycosylation and designed unnatural candidate polyprenols 1ag as alternative short lipid carriers for PglB-catalyzed glycosylation. The polyprenols were synthesized from building blocks 2ad and 3a and 3b.

    Scheme 1

    Scheme 1. Syntheses of Polyprenol Variantsa

    a(i) BuLi, THF, 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (DMTP), −78 °C. Yield: 4a = 92%, 4b = 93%, 4c = 83%, 4d = 63%, 4e = 67%, 4f = 74%. (ii) (1) TBAF, THF, RT, 4 h; (2) LiEt3BH, (dppp)PdCl2, THF, 0 °C–RT. Yield: 1a= 65%, 1b = 57%, 1c = 50%, 1d = 70%, 1e = 60%, 1f = 54%.

    Scheme 2

    Scheme 2. Syntheses of Lipid-linked Oligosaccharides and use in Glycopeptide Synthesisa

    a(i) 5ag, TBAP, TCA, DCM, RT; 5h, POCl3, Et3N, 2h. (ii) (1) CDI, DMF; (2) MeOH; (3) 6, DMF, RT, 3–5 days. (iii) NaOMe, MeOH. Yield over 3 steps: 8a = 17%, 8b = 23%, 8c = 9%, 8d = 17%, 8e = 9%, 8f = 38%, 8g = 29%, 8h = 32%, 13 = 22%, 14 = 30%. Extension reactions (blue arrows, 5–94%); see SI for further details.

    Figure 2

    Figure 2. Peptide and protein glycosylation. (a) Fluorescent electrophoretic analysis of peptide glycosylation with lipids (8ah) (− = no lipid; + = lipid extracted and enriched from E. coli cells producing C. jejuni heptasaccharide-linked undecaprenyl pyrophosphate); [glycolipid] = [peptide] 20 μM; [PglB] = 0.44 μM. (b) ES-MS of in vitro N-linked protein (AcrA) glycosylation with 8c; >95% diglycosylation.

  • References

    ARTICLE SECTIONS
    Jump To

    This article references 43 other publications.

    1. 1
      Spiro, R. G. Glycobiology 2002, 12, 43R
    2. 2
      Walsh, C. T.; Garneau-Tsodikova, S.; Gatto, G. J. Angew. Chem., Int. Ed. 2005, 44, 7342
    3. 3
      Ohtsubo, K.; Marth, J. D. Cell 2006, 126, 855
    4. 4
      Szymanski, C. M.; Yao, R.; Ewing, C. P.; Trust, T. J.; Guerry, P. Mol. Microbiol. 1999, 32, 1022
    5. 5
      Young, N. M.; Brisson, J. R.; Kelly, J.; Watson, D. C.; Tessier, L.; Lanthier, P. H.; Jarrell, H. C.; Cadotte, N.; St Michael, F.; Aberg, E.; Szymanski, C. M. J. Biol. Chem. 2002, 277, 42530
    6. 6
      Linton, D.; Allan, E.; Karlyshev, A. V.; Cronshaw, A. D.; Wren, B. W. Mol. Microbiol. 2002, 43, 497
    7. 7
      Scott, N. E.; Parker, B. L.; Connolly, A. M.; Paulech, J.; Edwards, A. V. G.; Crossett, B.; Falconer, L.; Kolarich, D.; Djordjevic, S. P.; Højrup, P.; Packer, N. H.; Larsen, M. R.; Cordwell, S. J. Mol. Cell. Proteomics 2011, 10, M000031
    8. 8
      Schwarz, F.; Lizak, C.; Fan, Y.-Y.; Fleurkens, S.; Kowarik, M.; Aebi, M. Glycobiology 2011, 21, 45
    9. 9
      Jervis, A. J.; Langdon, R.; Hitchen, P.; Lawson, A. J.; Wood, A.; Fothergill, J. L.; Morris, H. R.; Dell, A.; Wren, B.; Linton, D. J. Bacteriol. 2010, 192, 5228
    10. 10
      Ielmini, M. V.; Feldman, M. F. Glycobiology 2011, 21, 734
    11. 11
      Larkin, A.; Chang, M. M.; Whitworth, G. E.; Imperiali, B. Nat. Chem. Biol. 2013, 9, 367
    12. 12
      Glover, K. J.; Weerapana, E.; Numao, S.; Imperiali, B. Chem. Biol. 2005, 12, 1311
    13. 13
      Wacker, M.; Feldman, M. F.; Callewaert, N.; Kowarik, M.; Clarke, B. R.; Pohl, N. L.; Hernandez, M.; Vines, E. D.; Valvano, M. A.; Whitfield, C.; Aebi, M. Proc. Natl. Acad. Sci. U.S.A. 2006, 103, 7088
    14. 14
      Feldman, M. F.; Wacker, M.; Hernandez, M.; Hitchen, P. G.; Marolda, C. L.; Kowarik, M.; Morris, H. R.; Dell, A.; Valvano, M. A.; Aebi, M. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 3016
    15. 15
      Schwarz, F.; Huang, W.; Li, C.; Schulz, B. L.; Lizak, C.; Palumbo, A.; Numao, S.; Neri, D.; Aebi, M.; Wang, L.-X. Nat. Chem. Biol. 2010, 6, 264
    16. 16
      Wacker, M.; Linton, D.; Hitchen, P. G.; Nita-Lazar, M.; Haslam, S. M.; North, S. J.; Panico, M.; Morris, H. R.; Dell, A.; Wren, B. W.; Aebi, M. Science 2002, 298, 1790
    17. 17
      Chen, M. M.; Weerapana, E.; Ciepichal, E.; Stupak, J.; Reid, C. W.; Swiezewska, E.; Imperiali, B. Biochemistry 2007, 46, 14342
    18. 18
      Li, L.; Woodward, R.; Ding, Y.; Liu, X.-w.; Yi, W.; Bhatt, V. S.; Chen, M.; Zhang, L.-w.; Wang, P. G. Biochem. Biophys. Res. Commun. 2010, 394, 1069
    19. 19
      Sato, K.; Inoue, S.; Onishi, A.; Uchida, N.; Minowa, N. J. Chem. Soc., Perkin Trans. 1 1981, 761
    20. 20
      Sato, K.; Miyamoto, O.; Inoue, S.; Furusawa, F.; Matsuhashi, Y. Chem. Lett. 1983, 12, 725
    21. 21
      Jaenicke, L.; Siegmund, H. Biol. Chem. Hoppe-Seyler 1986, 367, 787
    22. 22
      Inoue, S.; Kaneko, T.; Takahashi, Y.; Miyamoto, O.; Sato, K. J. Chem. Soc., Chem. Commun. 1987, 1036
    23. 23
      Grassi, D.; Lippuner, V.; Aebi, M.; Brunner, J.; Vasella, A. J. Am. Chem. Soc. 1997, 119, 10992
    24. 24
      Chen, L.; Men, H.; Ha, S.; Ye, X.-Y.; Brunner, L.; Hu, Y.; Walker, S. Biochemistry 2002, 41, 6824
    25. 25
      Chang, Y.-F.; Liu, C.-Y.; Guo, C.-W.; Wang, Y.-C.; Fang, J.-M.; Cheng, W.-C. J. Org. Chem. 2008, 73, 7197
    26. 26
      Meng, F.-C.; Chen, K.-T.; Huang, L.-Y.; Shih, H.-W.; Chang, H.-H.; Nien, F.-Y.; Liang, P.-H.; Cheng, T.-J. R.; Wong, C.-H.; Cheng, W.-C. Org. Lett. 2011, 13, 5306
    27. 27
      Hesek, D.; Lee, M.; Zajíček, J.; Fisher, J. F.; Mobashery, S. J. Am. Chem. Soc. 2012, 134, 13881
    28. 28
      Shih, H.-W.; Chang, Y.-F.; Li, W.-J.; Meng, F.-C.; Huang, C.-Y.; Ma, C.; Cheng, T.-J. R.; Wong, C.-H.; Cheng, W.-C. Angew. Chem., Int. Ed. 2012, 51, 10123
    29. 29
      Lizak, C.; Gerber, S.; Numao, S.; Aebi, M.; Locher, K. P. Nature 2011, 474, 350
    30. 30
      Jaenicke, L.; Siegmund, H.-U. Chem. Phys. Lipids 1989, 51, 159
    31. 31
      Danilov, L. L.; Druzhinina, T. N.; Kalinchuk, N. A.; Maltsev, S. D.; Shibaev, V. N. Chem. Phys. Lipids 1989, 51, 191
    32. 32
      Bernardes, G. J. L.; Davis, B. G. unpublished results, University of Oxford, 2007.
    33. 33
      Bernardes, G. J. L.; Kikkeri, R.; Maglinao, M.; Laurino, P.; Collot, M.; Hong, S. Y.; Lepenies, B.; Seeberger, P. H. Org. Biomol. Chem. 2010, 8, 4987
    34. 34
      Schagger, H. Nat. Protoc. 2006, 1, 16
    35. 35
      Wang, L.-X. Carbohydr. Res. 2008, 343, 1509
    36. 36
      Rich, J. R.; Withers, S. G. Nat. Chem. Biol. 2009, 5, 206
    37. 37
      Goodfellow, J. J.; Baruah, K.; Yamamoto, K.; Bonomelli, C.; Krishna, B.; Harvey, D. J.; Crispin, M.; Scanlan, C. N.; Davis, B. G. J. Am. Chem. Soc. 2012, 134, 8030
    38. 38
      Fernández-González, M.; Boutureira, O.; Bernardes, G. J.; Chalker, J. M.; Young, M.; Errey, J.; Davis, B. G. Chem. Sci. 2010, 1, 709
    39. 39
      Lomino, J. V.; Naegeli, A.; Orwenyo, J.; Amin, M. N.; Aebi, M.; Wang, L.-X. Bioorg. Med. Chem. 2013, 21, 2262
    40. 40
      Gamblin, D. P.; Garnier, P.; van Kasteren, S.; Oldham, N. J.; Fairbanks, A. J.; Davis, B. G. Angew. Chem., Int. Ed. 2004, 43, 828
    41. 41
      Ye, X.-Y.; Lo, M.-C.; Brunner, L.; Walker, D.; Kahne, D.; Walker, S. J. Am. Chem. Soc. 2001, 123, 3155
    42. 42
      Liu, C.-Y.; Guo, C.-W.; Chang, Y.-F.; Wang, J.-T.; Shih, H.-W.; Hsu, Y.-F.; Chen, C.-W.; Chen, S.-K.; Wang, Y.-C.; Cheng, T.-J.; Ma, C.; Wong, C.-H.; Fang, J.-M.; Cheng, W.-C. Org. Lett. 2010, 12, 1608
    43. 43
      Lehrer, J.; Vigeant, K. A.; Tatar, L. D.; Valvano, M. A. J. Bacteriol. 2007, 189, 2618
  • Supporting Information

    Supporting Information

    ARTICLE SECTIONS
    Jump To

    Full procedures. This material is available free of charge via the Internet at http://pubs.acs.org.

    Terms & Conditions

    Electronic Supporting Information files are available without a subscription to ACS Web Editions. The American Chemical Society holds a copyright ownership interest in any copyrightable Supporting Information. Files available from the ACS website may be downloaded for personal use only. Users are not otherwise permitted to reproduce, republish, redistribute, or sell any Supporting Information from the ACS website, either in whole or in part, in either machine-readable form or any other form without permission from the American Chemical Society. For permission to reproduce, republish and redistribute this material, requesters must process their own requests via the RightsLink permission system. Information about how to use the RightsLink permission system can be found at http://pubs.acs.org/page/copyright/permissions.html.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

OOPS

You have to login with your ACS ID befor you can login with your Mendeley account.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE